Nanobiotix S.A. is a late-stage clinical development company pioneering physics-based therapeutic approaches using proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. Its lead product candidate is JNJ-1900 (NBTXR3), licensed to Janssen (J&J) for global development and commercialization. The company finances operations through European Investment Bank loans, a royalty financing with HCRx, public funding, research tax credits, and milestone payments from licensing agreements.
216 total filings indexed. 216 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001760854 |
| Ticker | NBTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | I0 |
| Website | https://www.nanobiotix.com |
| Listed | 2020-12-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NBTX (~200 tokens, structured JSON with cryptographic provenance)